ask="N/A"
ask_size="N/A"
average_daily_volume="989578"
bid="23.00"
bid_size="100"
book_value="5.75"
change="+0.85"
change_from_200_day_moving_average="9.12"
change_from_50_day_moving_average="7.46"
change_from_52_week_high="-3.10"
change_From_52_week_low="15.66"
change_in_percent="+3.14%"
close="27.90"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.25"
ebitda="-70.16M"
eps_estimate_current_year="-2.37"
eps_estimate_next_quarter="-0.61"
eps_estimate_next_year="-2.79"
ex_dividend_date="N/A"
float_shares="24615000"
high="28.70"
high_52_weeks="31.00"
last_trade_date="3/3/2017"
last_trade_price="27.90"
last_trade_size="220517"
last_trade_time="4:00pm"
low="27.00"
low_52_weeks="12.24"
market_capitalization="1.04B"
moving_average_200_day="18.78"
moving_average_50_day="20.44"
name="Global Blood Therapeutics
Inc."
notes="N/A"
one_year_target_price="50.71"
open="28.50"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+48.55%"
percent_change_from_50_day_moving_average="+36.52%"
percent_change_from_52_week_high="-10.00%"
percent_change_from_52_week_low="+127.94%"
previous_close="27.05"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.70"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="37316000"
short_ratio="9.70"
stock_exchange="NMS"
symbol="GBT"
volume="1520263"
weeks_range_52="12.24 - 31.00"
